Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
about
Barrett's oesophagus and adenocarcinomaLow Level of Her-2 Locus Amplification by Fluorescent In Situ Hybridization Does Not Correlate with Her-2 Protein Overexpression by Immunohistochemistry in Barrett's Esophagus.Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancerAssociation between HSP90 and Her2 in gastric and gastroesophageal carcinomas.Barrett's esophagus: histopathologic definitions and diagnostic criteria.Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC).Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 statusUtility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus.HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.MUC4 as a diagnostic marker in cancer.Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas.2-Triazenoazaindoles: α novel class of triazenes inducing transcriptional down-regulation of EGFR and HER-2 in human pancreatic cancer cells.Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha.MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.Molecular alterations during development of esophageal adenocarcinoma.A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk.Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis.Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation.Claudin expression in Barrett's esophagus and adenocarcinoma.
P2860
Q24791935-627D5878-DC23-4147-AA71-CF42230B4BB6Q33984756-E1F59B5E-CB7E-4198-A5E8-A18A565689DBQ34094855-35BE6A32-CC15-4A34-870D-5A4F8A7CD28EQ34452046-6C533790-091A-437F-A666-01A6FC8A60C8Q34852929-118C1C24-45FE-4F78-80B9-26DF89CEE01EQ35630825-93F9744F-5EA4-4B31-9E0A-6DED27F6594BQ36101895-97F24589-F782-4D85-9E9A-52FD5DA17F51Q36410392-A0EC19D7-3FB9-4FAF-B796-BC8A80612A0FQ36458793-BCE9C1F1-3665-426B-9F15-3684C03B05E9Q37495646-F9860FB3-4016-4182-87F0-B4D25A966F7EQ37522215-24BA7546-C5AC-4C07-8237-E1EB89EF2B7EQ38089784-E3B853C7-9F48-45F0-BFAF-1EFD42868705Q38412375-DAC18F04-D637-4059-BBC1-2650C6432FF6Q38444122-80C13441-8715-47B6-8407-CB2550279709Q39434302-F6AD63DA-0AB0-4E53-9EB4-28936ED01EEBQ40220702-FF0B2A7B-1F45-41E6-B42B-EEAC9F55CB0DQ43010427-BDFB6D4C-EC11-4799-A0E1-14E7A397BCF7Q46488823-98FB4EBB-A6CD-4C48-8B43-A97B88FBE242Q46758246-92BE2646-1A10-4760-9277-3F5CC2299961Q47757344-0FDA1A7E-36AE-443A-A936-B419694562C6Q52854999-7113DBF5-9AE9-4F7E-9370-AA52FAC33C69Q54501808-73C9E73F-909B-45B6-91DA-B204F3BA874CQ54594739-B81C956F-BA5D-47B3-AE0D-B5DCCA22E62EQ54646160-65A98E6D-AE5C-4153-9FCD-5E98842E4A40
P2860
Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Her-2/neu gene amplification, ...... quence of Barrett's esophagus.
@ast
Her-2/neu gene amplification, ...... quence of Barrett's esophagus.
@en
type
label
Her-2/neu gene amplification, ...... quence of Barrett's esophagus.
@ast
Her-2/neu gene amplification, ...... quence of Barrett's esophagus.
@en
prefLabel
Her-2/neu gene amplification, ...... quence of Barrett's esophagus.
@ast
Her-2/neu gene amplification, ...... quence of Barrett's esophagus.
@en
P2093
P2860
P1476
Her-2/neu gene amplification, ...... quence of Barrett's esophagus.
@en
P2093
H Braselmann
H Zitzelsberger
J R Siewert
P2860
P2888
P304
P356
10.1038/LABINVEST.3780289
P577
2001-06-01T00:00:00Z
P5875
P6179
1022455862